A facility that provides transfusion services must meet all of the requirements of this section and document all transfusion-related activities.
(a) Arrangement for services.
The facility must have a transfusion service agreement reviewed and approved by the responsible party(ies) that govern the procurement, transfer, and availability of blood and blood products.
(b) Provision of testing.
The facility must provide prompt ABO grouping, D(Rho) typing, unexpected antibody detection, compatibility testing, and laboratory investigation of transfusion reactions on a continuous basis through a CLIA-certified laboratory or a laboratory meeting equivalent requirements as determined by CMS.
(c) Blood and blood products storage and distribution.
(1)
If a facility stores or maintains blood or blood products for transfusion outside of a monitored refrigerator, the facility must ensure the storage conditions, including temperature, are appropriate to prevent deterioration of the blood or blood product.
(2)
The facility must establish and follow policies to ensure positive identification of a blood or blood product recipient.
(d) Investigation of transfusion reactions.
The facility must have procedures for preventing transfusion reactions and when necessary, promptly identify, investigate, and report blood and blood product transfusion reactions to the laboratory and, as appropriate, to Federal and State authorities.